In a recent webinar hosted by Advisory Board, Optum Advisory experts shared strategies, lessons, and insights to help healthcare organizations thrive in value-based care.
Many organizations still equate VBC with shared savings or risk contracting, overlooking its broader strategic potential. "Successful organizations view value-based care much more broadly… as part of the solution to all of those problems," said Greg Shufelt, referencing hospital capacity constraints and suboptimal managed care contracts.
A deeper challenge is the fear of risk. "The biggest issue I see is really the level of commitment to managing risk and making it a part of the organization's DNA," said Jeremiah Reuter. Risk spans financial, operational, regulatory, and clinical domains.
Most systems are still structurally optimized for fee-for-service. "It's a structural problem," said Carol Chouinard, calling for better tools and cross-functional collaboration to support population health and care coordination.
Eight components drive VBC success:
"These are not optional," said Shufelt. "Success in one area drives success in another."
Providers often do the hard work of transformation but struggle to get credit from payers. Showing measurable impact is critical.
Use a data-driven pitch deck when negotiating with payers. "Value-based contracting is contracting for the value that you're creating," said Shufelt. The deck should include proof points on total cost of care, quality outcomes, and clinical documentation — benchmarked against market and competitors.
"This is where you start to leverage the data and analytics," he added. "Ideally where you are versus the market, where you are versus your competitors — having that line of sight becomes really important when you're sitting down with a payer."
"There are two possible outcomes … we do manage populations more efficiently, or we have an opportunity to manage them more efficiently."
That opportunity is the foundation for transformation. This proactive approach helps shift the dynamic from passive acceptance of payer terms to true partnership.
Treat VBC as a partnership strategy. "Payers are enablers," said Shufelt. "They've got the data… the core things that you're going to need to be successful."
Health plans must also recognize the value of provider-patient relationships.
"We need to partner very closely with providers who have the trusted relationship… that is really the way to go."
This shift requires both sides to align around shared goals for cost, quality, and patient experience.
When disruptive tools — like AI, personalized outreach, and real-time clinical insights — are fully integrated, they transform care delivery. "Technology is not an accessory to value-based care — it's the engine," said Chouinard. He described a future where providers begin their day with a VBC "journal" that integrates patient data, risk assessments, and care recommendations.
"It's about using a lot of the insights for what's the best next action for patients… More and more, these interactions are going to be automated," he said.
Generative AI could be transformative. "The change that we're going to be seeing is how Gen AI is being used to deliver care… is probably as important as when we went digital in the first place," said Chouinard. These technologies can automate documentation, surface real-time insights, and personalize patient outreach — dramatically improving both provider efficiency and patient experience.
But the infrastructure isn't there yet. "We don't have the same type of platform—integrated overall and really all-encompassing — that we've had in the fee-for-service world," he cautioned.
Life sciences companies also have a role in VBC.
"It's taking their clinical studies and their proof points and creating a value story that's really built around the needs of their stakeholder partner."
Long-term outcomes may not resonate with stakeholders focused on short-term financial performance. "It can't be reducing utilization five or ten years down the road," he said. "That's not going to resonate with the risk-bearing entity that's trying to manage cost this year."
Commercial VBC faces structural challenges, including fragmented risk-bearing entities and employer churn. "It cannot be about underwriting," said Reuter. "We need to have an impact on cost and quality — real cost, real quality."
The "silver tsunami" of aging Medicare-eligible patients is accelerating demand for sustainable care models. "You're not going to negotiate your way to sustainability… it's going to come through value-based care incentives," said Shufelt.
"If you don't manage this population… they're going to fill up your beds with low acuity medical admissions that you don't have any margin on," he added. In this context, VBC isn't just a strategic initiative — it's a financial imperative.
Rising commercial costs will also drive adoption. "This is going to create tremendous pressures," said Reuter. He's encouraged by the growing demand for measurable outcomes. "Can we value, as actuaries, the effectiveness of our solution? What value are we bringing to the patients that we are looking to have impacts on?"
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.